The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Gareev I.F.
Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia
Beylerli O.A.
Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia
Diagnostic and Prognostic Potential of MicroRNA in Deep Vein Thrombosis
Journal: Journal of Venous Disorders. 2019;13(4): 318‑325
Views: 1008
Downloaded: 28
To cite this article:
Gareev IF, Beylerli OA. Diagnostic and Prognostic Potential of MicroRNA in Deep Vein Thrombosis. Journal of Venous Disorders.
2019;13(4):318‑325. (In Russ.)
https://doi.org/10.17116/flebo201913041318
Deep vein thrombosis (DVT) is a common disease that has a serious consequence for patients, such as pulmonary embolism. Over the past decade, numerous studies have been conducted to find reliable biomarkers for early diagnosis and prediction of DVT. MiRNAs are endogenously expressed RNA molecules 18—22 nucleotides in length that suppress gene expression at the post-transcriptional level by binding to the 3′-untranslated region (3’UTR) of mRNA-targets. MicroRNAs are involved into almost all biological processes, including cell proliferation, apoptosis and differentiation. It is known that miRNAs have an essential role in cardiovascular including disorders of hemostasis. There is evidence that miRNAs are secreted from cells in human biological fluids in passive and active fashions. These miRNAs are called circulating. Changes in expression profile of certain circulating miRNAs reflect physiological or pathological cellular state in which miRNAs are modified and secreted into human biological fluids, such as blood, urine, cerebrospinal fluid, saliva, etc. Circulating miRNAs may be detected in various forms (enclosed in exosomes or associated with Ago2 proteins). Thanks to these forms of transport, circulating miRNAs are stable and protected from degradation by RNase. Therefore, circulating miRNAs are considered as new potential biomarkers of interest in many diseases, including DVT. This work is aimed at studying current knowledge about the potential use of circulating miRNAs as diagnostic and prognostic biomarkers of DVT, as well as the role of endogenous miRNAs in impaired hemostasis.
Keywords:
Authors:
Gareev I.F.
Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia
Beylerli O.A.
Bashkir State Medical University of the Ministry of Health of the Russia, Ufa, Russia
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.